Global Acute Ischemic Stroke Therapeutics Market Research Report 2023

Report ID: 1983146 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acute Ischemic Stroke Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Thrombolytic Therapeutics
        1.2.3 Antihypertensive Therapeutics
        1.2.4 Antiplatelet Therapeutics
        1.2.5 Anticoagulants
    1.3 Market by Application
        1.3.1 Global Acute Ischemic Stroke Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Center
        1.3.4 Diagnostic Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Acute Ischemic Stroke Therapeutics Market Perspective (2017-2028)
    2.2 Acute Ischemic Stroke Therapeutics Growth Trends by Region
        2.2.1 Acute Ischemic Stroke Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Acute Ischemic Stroke Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Acute Ischemic Stroke Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Acute Ischemic Stroke Therapeutics Market Dynamics
        2.3.1 Acute Ischemic Stroke Therapeutics Industry Trends
        2.3.2 Acute Ischemic Stroke Therapeutics Market Drivers
        2.3.3 Acute Ischemic Stroke Therapeutics Market Challenges
        2.3.4 Acute Ischemic Stroke Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Acute Ischemic Stroke Therapeutics Players by Revenue
        3.1.1 Global Top Acute Ischemic Stroke Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Acute Ischemic Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Acute Ischemic Stroke Therapeutics Revenue
    3.4 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio
        3.4.1 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Therapeutics Revenue in 2021
    3.5 Acute Ischemic Stroke Therapeutics Key Players Head office and Area Served
    3.6 Key Players Acute Ischemic Stroke Therapeutics Product Solution and Service
    3.7 Date of Enter into Acute Ischemic Stroke Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Ischemic Stroke Therapeutics Breakdown Data by Type
    4.1 Global Acute Ischemic Stroke Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Type (2023-2028)
5 Acute Ischemic Stroke Therapeutics Breakdown Data by Application
    5.1 Global Acute Ischemic Stroke Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Acute Ischemic Stroke Therapeutics Market Size (2017-2028)
    6.2 North America Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022)
    6.3 North America Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Acute Ischemic Stroke Therapeutics Market Size (2017-2028)
    7.2 Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Acute Ischemic Stroke Therapeutics Market Size (2017-2028)
    9.2 Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Detail
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Acute Ischemic Stroke Therapeutics Introduction
        11.1.4 Bayer Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022)
        11.1.5 Bayer Recent Development
    11.2 Boehringer Ingelheim
        11.2.1 Boehringer Ingelheim Company Detail
        11.2.2 Boehringer Ingelheim Business Overview
        11.2.3 Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Introduction
        11.2.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022)
        11.2.5 Boehringer Ingelheim Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Acute Ischemic Stroke Therapeutics Introduction
        11.3.4 Roche Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Sanofi
        11.4.1 Sanofi Company Detail
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Acute Ischemic Stroke Therapeutics Introduction
        11.4.4 Sanofi Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022)
        11.4.5 Sanofi Recent Development
    11.5 Biogen
        11.5.1 Biogen Company Detail
        11.5.2 Biogen Business Overview
        11.5.3 Biogen Acute Ischemic Stroke Therapeutics Introduction
        11.5.4 Biogen Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022)
        11.5.5 Biogen Recent Development
    11.6 Daiichi Sankyo
        11.6.1 Daiichi Sankyo Company Detail
        11.6.2 Daiichi Sankyo Business Overview
        11.6.3 Daiichi Sankyo Acute Ischemic Stroke Therapeutics Introduction
        11.6.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022)
        11.6.5 Daiichi Sankyo Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Detail
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Acute Ischemic Stroke Therapeutics Introduction
        11.7.4 Pfizer Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022)
        11.7.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Acute Ischemic Stroke Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Thrombolytic Therapeutics
    Table 3. Key Players of Antihypertensive Therapeutics
    Table 4. Key Players of Antiplatelet Therapeutics
    Table 5. Key Players of Anticoagulants
    Table 6. Global Acute Ischemic Stroke Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Acute Ischemic Stroke Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Acute Ischemic Stroke Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Acute Ischemic Stroke Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Acute Ischemic Stroke Therapeutics Market Share by Region (2023-2028)
    Table 12. Acute Ischemic Stroke Therapeutics Market Trends
    Table 13. Acute Ischemic Stroke Therapeutics Market Drivers
    Table 14. Acute Ischemic Stroke Therapeutics Market Challenges
    Table 15. Acute Ischemic Stroke Therapeutics Market Restraints
    Table 16. Global Acute Ischemic Stroke Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Acute Ischemic Stroke Therapeutics Market Share by Players (2017-2022)
    Table 18. Global Top Acute Ischemic Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Ischemic Stroke Therapeutics as of 2021)
    Table 19. Ranking of Global Top Acute Ischemic Stroke Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Acute Ischemic Stroke Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Acute Ischemic Stroke Therapeutics Product Solution and Service
    Table 23. Date of Enter into Acute Ischemic Stroke Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Acute Ischemic Stroke Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Acute Ischemic Stroke Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Application (2017-2022)
    Table 31. Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Application (2023-2028)
    Table 33. North America Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Bayer Company Detail
    Table 44. Bayer Business Overview
    Table 45. Bayer Acute Ischemic Stroke Therapeutics Product
    Table 46. Bayer Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022) & (US$ Million)
    Table 47. Bayer Recent Development
    Table 48. Boehringer Ingelheim Company Detail
    Table 49. Boehringer Ingelheim Business Overview
    Table 50. Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Product
    Table 51. Boehringer Ingelheim Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022) & (US$ Million)
    Table 52. Boehringer Ingelheim Recent Development
    Table 53. Roche Company Detail
    Table 54. Roche Business Overview
    Table 55. Roche Acute Ischemic Stroke Therapeutics Product
    Table 56. Roche Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022) & (US$ Million)
    Table 57. Roche Recent Development
    Table 58. Sanofi Company Detail
    Table 59. Sanofi Business Overview
    Table 60. Sanofi Acute Ischemic Stroke Therapeutics Product
    Table 61. Sanofi Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022) & (US$ Million)
    Table 62. Sanofi Recent Development
    Table 63. Biogen Company Detail
    Table 64. Biogen Business Overview
    Table 65. Biogen Acute Ischemic Stroke Therapeutics Product
    Table 66. Biogen Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. Biogen Recent Development
    Table 68. Daiichi Sankyo Company Detail
    Table 69. Daiichi Sankyo Business Overview
    Table 70. Daiichi Sankyo Acute Ischemic Stroke Therapeutics Product
    Table 71. Daiichi Sankyo Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022) & (US$ Million)
    Table 72. Daiichi Sankyo Recent Development
    Table 73. Pfizer Company Detail
    Table 74. Pfizer Business Overview
    Table 75. Pfizer Acute Ischemic Stroke Therapeutics Product
    Table 76. Pfizer Revenue in Acute Ischemic Stroke Therapeutics Business (2017-2022) & (US$ Million)
    Table 77. Pfizer Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Ischemic Stroke Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Thrombolytic Therapeutics Features
    Figure 3. Antihypertensive Therapeutics Features
    Figure 4. Antiplatelet Therapeutics Features
    Figure 5. Anticoagulants Features
    Figure 6. Global Acute Ischemic Stroke Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Surgical Center Case Studies
    Figure 9. Diagnostic Centers Case Studies
    Figure 10. Acute Ischemic Stroke Therapeutics Report Years Considered
    Figure 11. Global Acute Ischemic Stroke Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Acute Ischemic Stroke Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Acute Ischemic Stroke Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Acute Ischemic Stroke Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Acute Ischemic Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Ischemic Stroke Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Therapeutics Revenue in 2021
    Figure 17. North America Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Acute Ischemic Stroke Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Acute Ischemic Stroke Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Acute Ischemic Stroke Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Bayer Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2017-2022)
    Figure 46. Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2017-2022)
    Figure 47. Roche Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2017-2022)
    Figure 48. Sanofi Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2017-2022)
    Figure 49. Biogen Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2017-2022)
    Figure 50. Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2017-2022)
    Figure 51. Pfizer Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Boehringer Ingelheim
Roche
Sanofi
Biogen
Daiichi Sankyo
Pfizer
Frequently Asked Questions
Acute Ischemic Stroke Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Ischemic Stroke Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Ischemic Stroke Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Adaptive Robotics

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Adult Diaper

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Adult Stores

Adult Stores market is segmented by players, region (country), by Type and by Application. Player ... Read More